NAUT · 10-Q · 2026Q1 · Full report

Headcount / Restructuring

Nautilus Biotechnology, Inc. · 2026-04-28 · Importance 34 · Surprise 42

Nautilus implemented a workforce reduction in the first quarter of 2025. Management attributes part of the year-over-year decreases in both R&D and SG&A expenses to cost savings from that reduction in force. The filing states the cost-saving initiatives resulted in reductions to personnel-related expenses during fiscal year 2025. The company continues to expect R&D and SG&A to increase in absolute dollars over time as it rebuilds teams to support development and commercialization.

Key facts

• Cost-saving initiatives from the workforce reduction implemented in the first quarter of 2025 resulted in reductions to personnel-related expenses during fiscal year 2025.
• Nautilus implemented a workforce reduction in the first quarter of 2025.